These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

237 related items for PubMed ID: 8306240

  • 1. The multiplicity of actions of benzodiazepine receptor ligands.
    Haefely WE, Martin JR, Richards JG, Schoch P.
    Can J Psychiatry; 1993 Nov; 38 Suppl 4():S102-8. PubMed ID: 8306240
    [Abstract] [Full Text] [Related]

  • 2. [GABA(A) benzodiazepine receptors and epilepsy].
    Sieghart W.
    Wien Klin Wochenschr; 1990 Mar 30; 102(7):197-201. PubMed ID: 2160756
    [Abstract] [Full Text] [Related]

  • 3. Partial agonists of the benzodiazepine receptor: from animal data to results in patients.
    Haefely W.
    Adv Biochem Psychopharmacol; 1988 Mar 30; 45():275-92. PubMed ID: 2459921
    [Abstract] [Full Text] [Related]

  • 4. Point mutations of the alpha 1 beta 2 gamma 2 gamma-aminobutyric acid(A) receptor affecting modulation of the channel by ligands of the benzodiazepine binding site.
    Buhr A, Baur R, Malherbe P, Sigel E.
    Mol Pharmacol; 1996 Jun 30; 49(6):1080-4. PubMed ID: 8649346
    [Abstract] [Full Text] [Related]

  • 5. Pharmacology of the human gamma-aminobutyric acidA receptor alpha 4 subunit expressed in Xenopus laevis oocytes.
    Whittemore ER, Yang W, Drewe JA, Woodward RM.
    Mol Pharmacol; 1996 Nov 30; 50(5):1364-75. PubMed ID: 8913369
    [Abstract] [Full Text] [Related]

  • 6. Relationship between benzodiazepine receptor occupancy and functional effects in vivo of four ligands of differing intrinsic efficacies.
    Facklam M, Schoch P, Bonetti EP, Jenck F, Martin JR, Moreau JL, Haefely WE.
    J Pharmacol Exp Ther; 1992 Jun 30; 261(3):1113-21. PubMed ID: 1318371
    [Abstract] [Full Text] [Related]

  • 7. Neuroactive steroid actions at the GABAA receptor.
    Lan NC, Gee KW.
    Horm Behav; 1994 Dec 30; 28(4):537-44. PubMed ID: 7729823
    [Abstract] [Full Text] [Related]

  • 8. Pharmacology of tolerance to benzodiazepine receptor ligands.
    Płaźnik A.
    Pol J Pharmacol; 1995 Dec 30; 47(6):489-99. PubMed ID: 8868371
    [Abstract] [Full Text] [Related]

  • 9. Allosteric ligands and their binding sites define γ-aminobutyric acid (GABA) type A receptor subtypes.
    Olsen RW.
    Adv Pharmacol; 2015 Dec 30; 73():167-202. PubMed ID: 25637441
    [Abstract] [Full Text] [Related]

  • 10. Characterization of bicuculline/baclofen-insensitive (rho-like) gamma-aminobutyric acid receptors expressed in Xenopus oocytes. II. Pharmacology of gamma-aminobutyric acidA and gamma-aminobutyric acidB receptor agonists and antagonists.
    Woodward RM, Polenzani L, Miledi R.
    Mol Pharmacol; 1993 Apr 30; 43(4):609-25. PubMed ID: 8386310
    [Abstract] [Full Text] [Related]

  • 11. Partial agonists of benzodiazepine receptors for the treatment of epilepsy, sleep, and anxiety disorders.
    Haefely W, Facklam M, Schoch P, Martin JR, Bonetti EP, Moreau JL, Jenck F, Richards JG.
    Adv Biochem Psychopharmacol; 1992 Apr 30; 47():379-94. PubMed ID: 1324584
    [Abstract] [Full Text] [Related]

  • 12. Receptor and voltage-operated ion channels in the central nervous system.
    Antkiewicz-Michaluk L.
    Pol J Pharmacol; 1995 Apr 30; 47(3):253-64. PubMed ID: 8714758
    [Abstract] [Full Text] [Related]

  • 13. Homomeric beta 1 gamma-aminobutyric acid A receptor-ion channels: evaluation of pharmacological and physiological properties.
    Krishek BJ, Moss SJ, Smart TG.
    Mol Pharmacol; 1996 Mar 30; 49(3):494-504. PubMed ID: 8643089
    [Abstract] [Full Text] [Related]

  • 14. Anticonvulsant efficacy of the low-affinity partial benzodiazepine receptor agonist ELB 138 in a dog seizure model and in epileptic dogs with spontaneously recurrent seizures.
    Löscher W, Potschka H, Rieck S, Tipold A, Rundfeldt C.
    Epilepsia; 2004 Oct 30; 45(10):1228-39. PubMed ID: 15461677
    [Abstract] [Full Text] [Related]

  • 15. Aspects of benzodiazepine receptor structure and function with relevance to drug tolerance and dependence.
    Schoch P, Moreau JL, Martin JR, Haefely WE.
    Biochem Soc Symp; 1993 Oct 30; 59():121-34. PubMed ID: 7910739
    [Abstract] [Full Text] [Related]

  • 16. Receptor subtype-dependent positive and negative modulation of GABA(A) receptor function by niflumic acid, a nonsteroidal anti-inflammatory drug.
    Sinkkonen ST, Mansikkamäki S, Möykkynen T, Lüddens H, Uusi-Oukari M, Korpi ER.
    Mol Pharmacol; 2003 Sep 30; 64(3):753-63. PubMed ID: 12920213
    [Abstract] [Full Text] [Related]

  • 17. The GABAA receptor: new insights from single-channel recording.
    Mathers DA.
    Synapse; 1987 Sep 30; 1(1):96-101. PubMed ID: 2905528
    [Abstract] [Full Text] [Related]

  • 18. 6,2'-Dihydroxyflavone, a subtype-selective partial inverse agonist of GABAA receptor benzodiazepine site.
    Wang F, Xu Z, Yuen CT, Chow CY, Lui YL, Tsang SY, Xue H.
    Neuropharmacology; 2007 Sep 30; 53(4):574-82. PubMed ID: 17681556
    [Abstract] [Full Text] [Related]

  • 19. Regulation of GABAA receptor channels by anticonvulsant and convulsant drugs and by phosphorylation.
    Macdonald RL, Twyman RE, Ryan-Jastrow T, Angelotti TP.
    Epilepsy Res Suppl; 1992 Sep 30; 9():265-77. PubMed ID: 1337441
    [Abstract] [Full Text] [Related]

  • 20. Biological function of GABAA/benzodiazepine receptor heterogeneity.
    Lüddens H, Korpi ER.
    J Psychiatr Res; 1995 Sep 30; 29(2):77-94. PubMed ID: 7545236
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.